These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9398212)

  • 1. Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor.
    Tanner KG
    Biochemistry; 1997 Dec; 36(48):14889-96. PubMed ID: 9398212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of epidermal growth factor receptor by epidermal growth factor.
    Sherrill JM; Kyte J
    Biochemistry; 1996 May; 35(18):5705-18. PubMed ID: 8639530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?
    Groenen LC; Walker F; Burgess AW; Treutlein HR
    Biochemistry; 1997 Apr; 36(13):3826-36. PubMed ID: 9092812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the EGF receptor by insertional mutations in its juxtamembrane regions.
    Sorokin A
    Oncogene; 1995 Oct; 11(8):1531-40. PubMed ID: 7478577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
    Sherrill JM; Kyte J
    Biochemistry; 1999 Mar; 38(10):3106-11. PubMed ID: 10074364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal inactivation of the protein tyrosine kinase of the epidermal growth factor receptor.
    Stein RA; Staros JV
    Biochemistry; 1996 Mar; 35(9):2878-84. PubMed ID: 8608124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
    Ge G; Wu J; Wang Y; Lin Q
    Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction.
    Sherrill JM
    Biochemistry; 1997 Oct; 36(42):12890-6. PubMed ID: 9335547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
    Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
    Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
    Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
    Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications.
    Le PU; Lenferink AE; Pinard M; Baardsnes J; Massie B; O'Connor-McCourt MD
    Protein Expr Purif; 2009 Apr; 64(2):108-17. PubMed ID: 19061959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
    Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
    Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
    van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
    Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficiency of self-phosphorylation for the activation of epidermal growth factor receptor.
    Sherrill JM
    Biochemistry; 1997 May; 36(19):5677-84. PubMed ID: 9153407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
    Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
    Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.
    Neelam B; Richter A; Chamberlin SG; Puddicombe SM; Wood L; Murray MB; Nandagopal K; Niyogi SK; Davies DE
    Biochemistry; 1998 Apr; 37(14):4884-91. PubMed ID: 9538006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.